Display options
Share it on

Curr Cardiol Rev. 2009 Nov;5(4):289-95. doi: 10.2174/157340309789317904.

Cardiac innervation and sudden cardiac death.

Current cardiology reviews

Masaki Ieda, Keiichi Fukuda

Affiliations

  1. Department of Regenerative Medicine and Advanced Cardiac Therapeutics, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

PMID: 21037846 PMCID: PMC2842961 DOI: 10.2174/157340309789317904

Abstract

The heart is extensively innervated and its performance is tightly controlled by the nervous system. Cardiac innervation density varies in diseased hearts leading to unbalanced neural activation and lethal arrhythmia. Diabetic sensory neuropathy causes silent myocardial ischemia, characterized by loss of pain perception during myocardial ischemia, which is a major cause of sudden cardiac death in diabetes mellitus (DM). Despite its clinical importance, the mechanisms underlying the control and regulation of cardiac innervation remain poorly understood.We found that cardiac innervation is determined by the balance between neural chemoattractants and chemorepellents within the heart. Nerve growth factor (NGF), a potent chemoattractant, is induced by endothelin-1 upregulation during development and is highly expressed in cardiomyocytes. By comparison, Sema3a, a neural chemorepellent, is highly expressed in the subendocardium of early stage embryos, and is suppressed during development. The balance of expression between NGF and Seme3a leads to epicardial-to-endocardial transmural sympathetic innervation patterning. We also found that downregulation of cardiac NGF leads to diabetic neuropathy, and that NGF supplementation rescues silent myocardial ischemia in DM. Cardiac innervation patterning is disrupted in Sema3a-deficient and Sema3a-overexpressing mice, leading to sudden death or lethal arrhythmias. The present review focuses on the regulatory mechanisms underlying cardiac innervation and the critical role of these processes in cardiac performance.

Keywords: Cardiac nerve; Sema3a; arrhythmia; nerve growth factor; silent myocardial ischemia; sudden cardiac death.

References

  1. Circ Res. 2007 Jun 22;100(12):1755-64 - PubMed
  2. Life Sci. 1999;65(22):2305-13 - PubMed
  3. Cardiovasc Res. 2001 May;50(2):409-16 - PubMed
  4. J Neurosci. 1997 Dec 15;17(24):9573-82 - PubMed
  5. Exp Neurol. 1998 Sep;153(1):23-34 - PubMed
  6. Circ Res. 1991 May;68(5):1204-15 - PubMed
  7. J Clin Invest. 2001 May;107(9):1083-92 - PubMed
  8. Circulation. 1997 Aug 19;96(4):1337-42 - PubMed
  9. Cardiovasc Pathol. 2002 Nov-Dec;11(6):326-31 - PubMed
  10. Lancet. 2003 Jul 5;362(9377):7-13 - PubMed
  11. Nat Med. 1997 Dec;3(12):1398-401 - PubMed
  12. J Clin Invest. 2004 Mar;113(6):876-84 - PubMed
  13. Cell. 2005 Oct 21;123(2):347-58 - PubMed
  14. Cell. 1994 Jun 3;77(5):627-38 - PubMed
  15. Neurosci Lett. 1996 Mar 8;206(1):33-6 - PubMed
  16. Exp Neurol. 1994 Nov;130(1):24-30 - PubMed
  17. J Neurosci Res. 1990 Jun;26(2):258-67 - PubMed
  18. Cell. 2001 Dec 14;107(6):801-13 - PubMed
  19. Cell. 1994 Mar 25;76(6):1001-11 - PubMed
  20. Cell. 2004 Jul 23;118(2):243-55 - PubMed
  21. Nat Med. 2007 May;13(5):604-12 - PubMed
  22. Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):795-801 - PubMed
  23. J Mol Cell Cardiol. 1998 Oct;30(10):2047-57 - PubMed
  24. J Cell Biol. 1995 Jul;130(1):137-48 - PubMed
  25. Diabetes. 1977 Dec;26(12):1147-58 - PubMed
  26. Circulation. 2002 Jul 30;106(5):620-5 - PubMed
  27. Circulation. 1994 Sep;90(3):1459-68 - PubMed
  28. Circ Res. 2004 Jul 9;95(1):76-83 - PubMed
  29. J Clin Invest. 2004 Dec;114(12):1741-51 - PubMed
  30. Exp Neurol. 2003 Feb;179(2):188-99 - PubMed
  31. Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12179-84 - PubMed
  32. Circ Res. 2005 Apr 29;96(8):823-30 - PubMed
  33. J Biol Chem. 1991 May 15;266(14):9180-5 - PubMed
  34. Dev Biol. 1995 May;169(1):309-21 - PubMed
  35. Circulation. 2002 Oct 22;106(17):2257-62 - PubMed
  36. Cardiovasc Res. 1998 May;38(2):348-55 - PubMed
  37. J Mol Cell Cardiol. 2004 Aug;37(2):439-48 - PubMed
  38. Br Heart J. 1993 May;69(5):430-5 - PubMed
  39. Circ Res. 1968 Mar;22(3):315-23 - PubMed
  40. J Cardiovasc Electrophysiol. 2003 Feb;14(2):191-5 - PubMed
  41. J Physiol. 2004 Aug 15;559(Pt 1):103-20 - PubMed
  42. Diabetes. 2004 Oct;53(10):2723-30 - PubMed
  43. Circ Res. 2000 Apr 14;86(7):816-21 - PubMed
  44. JAMA. 2000 Nov 1;284(17):2215-21 - PubMed
  45. Eur J Neurosci. 1995 May 1;7(5):1107-10 - PubMed
  46. Neuron. 1997 Sep;19(3):519-30 - PubMed
  47. Neuron. 1995 May;14(5):941-8 - PubMed
  48. Am J Physiol. 1990 Jun;258(6 Pt 2):H1796-805 - PubMed
  49. J Anat. 1999 Oct;195 ( Pt 3):341-57 - PubMed
  50. EMBO J. 1984 Dec 20;3(13):3183-9 - PubMed
  51. Circ Res. 2000 Apr 14;86(7):E80-4 - PubMed
  52. Circulation. 1994 Apr;89(4):1697-708 - PubMed
  53. Diabetes. 1999 Mar;48(3):603-8 - PubMed
  54. J Physiol. 2003 Sep 1;551(Pt 2):515-23 - PubMed
  55. Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2728-38 - PubMed
  56. Am J Cardiol. 1997 Nov 13;80(9B):35J-39J - PubMed
  57. Brain Res. 1984 Oct 29;321(1):111-8 - PubMed
  58. Circ Res. 1999 Feb 5;84(2):146-52 - PubMed
  59. Circulation. 2006 Nov 28;114(22):2351-63 - PubMed
  60. Dev Biol. 1999 Jun 15;210(2):411-27 - PubMed
  61. J Histochem Cytochem. 1986 Nov;34(11):1431-8 - PubMed
  62. Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2076-83 - PubMed
  63. Curr Opin Neurol. 1999 Oct;12(5):553-63 - PubMed
  64. Nat Neurosci. 1999 Aug;2(8):699-705 - PubMed
  65. Development. 2002 Feb;129(3):671-80 - PubMed
  66. Circulation. 2004 Sep 28;110(13):1826-31 - PubMed
  67. J Cardiovasc Electrophysiol. 2007 Jan;18(1):123-7 - PubMed
  68. Diabetes. 2002 Jul;51(7):2227-32 - PubMed
  69. Circulation. 2005 Dec 6;112(23):3617-23 - PubMed
  70. Circulation. 2000 Apr 25;101(16):1960-9 - PubMed
  71. Science. 2004 Apr 9;304(5668):292-6 - PubMed
  72. Nature. 1996 Oct 10;383(6600):525-8 - PubMed

Publication Types